Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Cash Flow (2020 - 2025)

Roivant Sciences' Net Cash Flow history spans 6 years, with the latest figure at $241.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 105.3% year-over-year to $241.2 million; the TTM value through Dec 2025 reached -$1.2 billion, up 86.34%, while the annual FY2025 figure was -$3.8 billion, 178.75% down from the prior year.
  • Net Cash Flow reached $241.2 million in Q4 2025 per ROIV's latest filing, up from -$2.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $5.0 billion in Q4 2023 to a low of -$4.6 billion in Q4 2024.
  • Average Net Cash Flow over 5 years is -$408.7 million, with a median of -$133.3 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: skyrocketed 1036.57% in 2023, then plummeted 14574.37% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $84.5 million in 2021, then crashed by 731.07% to -$533.0 million in 2022, then surged by 1036.57% to $5.0 billion in 2023, then plummeted by 191.15% to -$4.6 billion in 2024, then soared by 105.3% to $241.2 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Net Cash Flow are $241.2 million (Q4 2025), -$2.7 million (Q3 2025), and -$1.5 billion (Q2 2025).